Novo Nordisk A/S (Novo Nordisk A/S) Price-to-Operating-Cash-Flow

: 35.36 (As of Today)

View and export this data going back to . Start your Free Trial

As of today (2024-04-19), Novo Nordisk A/S's share price is $123.475. Novo Nordisk A/S's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.49. Hence, Novo Nordisk A/S's Price-to-Operating-Cash-Flow Ratio for today is 35.36.

The historical rank and industry rank for Novo Nordisk A/S's Price-to-Operating-Cash-Flow or its related term are showing as below:

NONOF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.41 Med: 22.38 Max: 37.38
Current: 35.83

During the past 13 years, Novo Nordisk A/S's highest Price-to-Operating-Cash-Flow Ratio was 37.38. The lowest was 11.41. And the median was 22.38.

NONOF's Price-to-Operating-Cash-Flow is ranked worse than
63.96% of 283 companies
in the Biotechnology industry
Industry Median: 24.39 vs NONOF: 35.83

Novo Nordisk A/S's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.31. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.49.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Novo Nordisk A/S was 39.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 20.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 13.80% per year.

During the past 13 years, Novo Nordisk A/S's highest 3-Year average Operating Cash Flow per Share Growth Rate was 136.20% per year. The lowest was -46.40% per year. And the median was 16.50% per year.

Novo Nordisk A/S Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Novo Nordisk A/S's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

19.66

19.22

30.78

27.02

28.81

Novo Nordisk A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																27.02	28.90	27.67	27.23	28.81

Competitive Comparison

For the Biotechnology subindustry, Novo Nordisk A/S's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novo Nordisk A/S Price-to-Operating-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's Price-to-Operating-Cash-Flow falls into.

Novo Nordisk A/S Price-to-Operating-Cash-Flow Calculation

Novo Nordisk A/S's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	123.475	/	3.492
	=	35.36

Novo Nordisk A/S's Share Price of today is $123.475.
Novo Nordisk A/S's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.49.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Novo Nordisk A/S Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (OTCPK:NONOF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

NVO:USA NOVOB:Mexico NVO:Mexico NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany N1VO34:Brazil NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, DK-2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.